ArticleThe Lancet. Rheumatology2022

Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study.

Jochen Pfeifer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.